参·考·文·献

［1］郑建铭，黄翀，鱼康康，等.慢性乙型病毒性肝炎慢加急性肝衰竭患者拉米夫定与恩替卡韦抗病毒治疗的短期病死率比较［J］.中国感染与化疗杂志，2018，18（2）：132-136.

［2］Huang C，Yu KK，Zheng JM，et al.Steroid treatment in patients with acute-on-chronic liver failure precipitated by hepatitis B：a 10-year cohort study in a university hospital in East China［J］.J Dig Dis，2019，20（1）：38-44.

［3］Li Q，Lu Q，Zhu MQ，et al.Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure［J］.BMC Gastroenterol，2020，20（1）：106.(https://www.daowen.com)

［4］Yang Q，Zhou Z，Yang X，et al.Latent cytomegalovirus reactivation in patients with liver failure：a 10-year retrospective casecontrol study，2011-2020［J］.Front Cell Infect Microbiol，2021，11：642500.

［5］Tverdek FP，Kofteridis D，Kontoyiannis DP.Antifungal agents and liver toxicity：a complex interaction［J］.Expert Rev Anti Infect Ther，2016，14：8，765-776.